Anti-PD-L1 antibody [28-8] - BSA and Azide free

16 product images

• 

  Flow Cytometry - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 flow cytometry staining of PDL-1 KO cells using rabbit anti-PD-L1 antibody
  
  Anti-PD-L1 antibody [28-8] ab205921 specificity testing by Flow Cytometry (KO testing): Loss of detection on KO cells.Strong detection with anti-PD-L1 (Anti-PD-L1 antibody [28-8] ab205921 clone 28-8) TALEN constructs targeting exon4 of human PD-L1 transcript variant 1 (NM_014143.3) and complete knock out (K.O) confirmed by deep sequencing in clone L2-14. Cell surface staining is almost completely eliminated in the L2987 L2-14 KO cell line. For recommended Flow Cytometry (Flow Cyt) protocol please refer to the protocol book in the protocol section. Alexa Fluor^® 488 (Alexa Fluor® 488 Anti-PD-L1 antibody [28-8] ab209959) and Alexa Fluor^® 647 (Alexa Fluor® 647 Anti-PD-L1 antibody [28-8] - Extracellular domain ab209960) conjugated versions are available for this clone.
  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of human tonsil using rabbit anti-PD-L1 antibody
  
  IHC image of Anti-PD-L1 antibody [28-8] ab205921 staining PD-L1 in human tonsil formalin fixed paraffin embedded tissue sections* performed on a Leica BOND RX (Polymer Refine kit). The section was pre-treated using heat mediated antigen retrieval with EDTA buffer (pH9 epitope retrieval solution 2) for 30 mins at 98°C. The section was then incubated with Anti-PD-L1 antibody [28-8] ab205921 5μg/ml working concentration for 60 mins at room temperature and detected using an HRP conjugated compact polymer system for 8 minutes at room temperature. DAB was used as the chromogen for 10 minutes at room temperature. The section was then counterstained with hematoxylin blued dehydrated cleared and mounted with DPX.

  For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions primary antibody concentration and antibody incubation times.

  *Tissue obtained from the Human Research Tissue Bank supported by the NIHR Cambridge Biomedical Research Centre

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  Immunohistochemical staining of PD-L1 in formalin fixed, paraffin embedded human non-squamous non-small cell lung cancer (NSQ-NSCLC) using Anti-PD-L1 antibody [28-8] ab205921 at a dilution of 1/400, incubated for an hour at room temperature. Heat mediated antigen retrieval was carried out in low pH buffer and the sample was blocked with peroxidase blocking buffer for 3 minutes.
  

  This image was courteously provided by Dr. Kai Schmitt from the Institute of Pathology, Saarbrücken-Rastpfuhl.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of human placenta using rabbit anti-PD-L1 antibody
  
  Paraformaldehyde-fixed paraffin-embedded human placenta tissue stained for PD-L1 using Anti-PD-L1 antibody [28-8] ab205921 at 1/100 dilution in immunohistochemical analysis.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  IHC image of Anti-PD-L1 antibody [28-8] ab205921 staining PD-L1 in PD-L1 Dynamic Range Analyte Control formalin fixed paraffin embedded cell lines (HistoCyte Laboratories

  ), performed on a Leica BOND RX (Polymer Refine kit). The section was pre-treated using heat mediated antigen retrieval with EDTA buffer (pH9, epitope retrieval solution 2) for 30 mins at 98°C. The section was then incubated with Anti-PD-L1 antibody [28-8] ab205921, 5μg/ml working concentration, for 60 mins at room temperature and detected using an HRP conjugated compact polymer system for 8 minutes at room temperature. DAB was used as the chromogen for 10 minutes at room temperature. The section was then counterstained with hematoxylin, blued, dehydrated, cleared and mounted with DPX.
  

  For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  Anti-PD-L1 antibody [28-8] (Anti-PD-L1 antibody [28-8] ab205921)
  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human tonsil tissue labelling PD-L1 with Anti-PD-L1 antibody [28-8] ab205921 at a dilution of 1:400. Heat mediated antigen retrieval was performed using AR9 antigen retrieval solution, and microwave treatment for 15 min at 20% power. Anti-Rabbit/Mouse HRP polymer (PerkinElmer Opal Polymer HRP Ms Plus Rb) was used as secondary antibody. Opal tyramide amplification was performed using Opal 520 fluorophore. Counterstained with DAPI stain. Image scanned with Vectra 3.0 and analyzed via Phenochart software.
  This image was courteously provided by Dr. Houssein Abdul Sater, Georgia Cancer Center.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  Anti-PD-L1 antibody [28-8] ab205921 specificity testing by Immunohistochemistry (KO testing): Loss of detection on KO Cells
  
  Strong IHC detection with anti-PD-L1 (Anti-PD-L1 antibody [28-8] ab205921, clone 28-8) is seen in human lung adenocarcinoma tumor cell line L2987. PDL1 gene was edited in L2987 cells using TALEN constructs targeting exon4 of human PD-L1, transcript variant 1 (NM_014143.3) and complete knock out (K.O) confirmed by deep sequencing in clone L2-14. IHC detection is completely eliminated in the L2987 L2-14 K.O. cell line.
  

  For recommended Immunohistochemistry (IHC) protocol, please refer to the protocol book in the Support&downloads section of Anti-PD-L1 antibody [28-8] ab205921.

  Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  Immunohistochemical analysis of CHO PD-L1 cells with Anti-PD-L1 antibody [28-8] ab205921 at 2 μg/ml.
  High power view
  A) Rabbit IgG, 5 μg/mL. No staining
  B) Anti PD-L1, 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 1)
  C) Anti PD-L1, 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 3)
  D) Anti PD-L1, 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 4)
  E) Anti PD-L1, 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 5)
  F) Anti PD-L1, 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 6)
  G) Anti PD-L1, 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 7)
  

  All batches/lots (1,3,4,5,6,7) showed consistent results.

  
  Note strong, moderate, and weak (red, yellow, and white arrows respectively) plasma membrane staining of CHO PD-L1 transfected cells

  For recommended Immunohistochemistry (IHC) protocol, please refer to the protocol book in the Support&downloads section of Anti-PD-L1 antibody [28-8] ab205921.

  Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of CHO cells using rabbit anti-PD-L1 antibody
  
  Immunohistochemical analysis of CHO Parental cells with Anti-PD-L1 antibody [28-8] ab205921 at 2 μg/ml.
  High power view
  A) Rabbit IgG 5 μg/mL. No staining
  B) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 1)
  C) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 3)
  D) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 4)
  E) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 5)
  F) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 6)
  G) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 7)

  All batches/lots (134567) showed consistent results.

  Note absence of PD-L1 expression in CHO parental cells.

  For recommended Immunohistochemistry (IHC) protocol please refer to the protocol book in the Support&downloads section.

  Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of lung NSCLC using rabbit anti-PD-L1 antibody
  
  Immunohistochemical analysis of Human Lung NSCLC with Anti-PD-L1 antibody [28-8] ab205921 at 2 μg/ml.
  High power view
  A) Rabbit IgG 5 μg/mL. No staining
  B) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 1)
  C) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 3)
  D) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 4)
  E) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 5)
  F) Anti PD-L1 2 μg/mL (Anti-PD-L1 antibody [28-8] ab205921 batches 6)

  All batches/lots (13456) showed consistent results.

  Note linear and complete or partial (arrows) PD-L1 staining of tumor cells. Tumor associated immune cells localized over the tumor margin exhibit positive plasma membrane staining (small arrows).

  For recommended Immunohistochemistry (IHC) protocol please refer to the protocol book in the Support&downloads section.

  Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human head and neck squamous cell carcinoma tissue labeling PD-L1 with Anti-PD-L1 antibody [28-8] ab205921 at 2 μg/ml. Counterstained with Hematoxylin.
  

  For antigen retrival buffer, Universal HIER antigen retrieval reagent (Universal HIER antigen retrieval reagent (10X) ab208572) was used.
  For IHC detection kit, Rabbit specific IHC polymer detection kit HRP/DAB (Rabbit specific IHC polymer detection kit HRP/DAB ab209101) is recommended.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of L2987 cells using rabbit anti-PD-L1 antibody
  
  Immunohistochemical analysis of formalin-fixed paraffin-embedded L2987 (Human lung adenocarcinoma cell line with endogenous PD-L1 expression) cells labeling PD-L1 with Anti-PD-L1 antibody [28-8] ab205921 at 2 μg/ml. Counterstained with Hematoxylin.

  For antigen retrival buffer Universal HIER antigen retrieval reagent (Universal HIER antigen retrieval reagent (10X) ab208572) was used.
  For IHC detection kit Rabbit specific IHC polymer detection kit HRP/DAB (Rabbit specific IHC polymer detection kit HRP/DAB ab209101) is recommended.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PD-L1 antibody [28-8] ab205921).

• 

  Multiplex immunohistochemistry - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  This data was developed using Anti-PD-L1 antibody [28-8] ab205921, the same antibody clone in a different buffer formulation.

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Human tonsil tissue staining PD-L1 with Anti-PD-L1 antibody [28-8] ab205921 at a 1:500 (2.19 ug/ml) dilution; PD1 with Anti-PD1 antibody [CAL20] ab237728 at 1:2000 (0.525 ug/ml) dilution and CD68 with Anti-CD68 antibody [EPR20545] ab213363 at 1:500 (1.26 ug/ml) dilution followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-CD68 (magenta; Opal^™690), anti-PD-L1 (green; Opal^™520) and anti-PD1 (red; Opal^™570) on human tonsil.
  
  Panel B: anti-PD-L1 stained on cells involved in T cell inhibition.
  
  Panel C: anti-PD1 stained on antigen-stimulated T cells.
  
  Panel D: anti-CD68 stained on macrophages.

  The section was incubated in three rounds of staining: in the order of Anti-CD68 antibody [EPR20545] ab213363 and Anti-PD-L1 antibody [28-8] ab205921 for 30 mins, then Anti-PD1 antibody [CAL20] ab237728 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal^™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of human tonsil using rabbit anti-PD-L1 antibody
  
  

  Immunohistochemical analysis of formalin-fixed paraffin-embedded human tonsil labelling PD-L1 with Anti-PD-L1 antibody [28-8] ab205921 at a dilution of 2µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32min with ULTRA cell conditioning solution (CC1 pH8.5). Anti-PD-L1 antibody [28-8] ab205921 anti PD-L1 antibody was incubated at 37°C for 16min. Sections were counterstained is with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

  This data was developed using Anti-PD-L1 antibody [28-8] ab205921, the same antibody clone in a different buffer formulation.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  PD-L1 immunohistochemistry staining of human placenta using rabbit anti-PD-L1 antibody
  
  

  Immunohistochemical analysis of formalin-fixed paraffin-embedded human placenta labelling PD-L1 with Anti-PD-L1 antibody [28-8] ab205921 at a dilution of 2µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32min with ULTRA cell conditioning solution (CC1 pH8.5). Anti-PD-L1 antibody [28-8] ab205921 anti PD-L1 antibody was incubated at 37°C for 16min. Sections were counterstained is with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

  This data was developed using Anti-PD-L1 antibody [28-8] ab205921, the same antibody clone in a different buffer formulation.

• 

  Western blot - Anti-PD-L1 antibody [28-8] - BSA and Azide free (ab228413)

  Anti-PD-L1 antibody [73-10] ab228415 works better than Anti-PD-L1 antibody [28-8] ab205921 in western blot testing.
  Blocking/Diluting buffer and concentration: 5% NFDM/TBST
  This data was developed using Anti-PD-L1 antibody [28-8] ab205921, the same antibody clone in a different buffer formulation.

  All lanes: Western blot - Anti-PD-L1 antibody [28-8] (Anti-PD-L1 antibody [28-8] ab205921) at 1/1000 dilution

  Lane 1: MDA-MB-231(human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg

  Lane 2: U-87 MG (human glioblastoma astrocytoma epithelial cell) whole cell lysate at 20 µg

  Lane 3: PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg

  Lane 4: A375 (human malignant melanoma epithelial cell) whole cell lysate at 20 µg

  Lane 5: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

  Lane 6: A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution

  Observed band size: 40-60 kDa

  Exposure time: 100s

  Anti-PD-L1 antibody [73-10] ab228415 works better than Anti-PD-L1 antibody [28-8] ab205921 in western blot testing.
  Blocking/Diluting buffer and concentration: 5% NFDM/TBST